Tivozanib kidney cancer drug. Close-up of a tub containing capsules of the kidney cancer drug tivozanib, marketed under the name Fotivda. Tivozanib is an oral VEGF receptor tyrosine kinase inhibitor used for the treatment of first line (treatment naive) patients with renal cell carcinoma.
| px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP28465200
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
Restriction:
Editorial use only
abnormalbiochemicalbiochemistrywhitebackgroundcapsulecapsuleschemicalchemistryclose-upconditiondetaildisorderdrugdrugsfirstlinefotivdahealthcarekidneycancermedicalmedicinenephrologyno-onenobodyoncologicaloncologyoralpackagedpackagingpharmaceuticpharmaceuticalpharmacologicalpharmacologyprescriptionreceptortyrosinekinaseinhibitorrenalrenalcellcarcinomativozanibtreatmenttubunhealthyvegf
abnormalbackgroundbiochemicalbiochemistrycancercapsulecapsulescarcinomacellchemicalchemistryclose-upconditiondetaildisorderdrugdrugsfirstfotivdahealthcareinhibitorkidneykinaselinemedicalmedicinenephrologyno-onenobodyoncologicaloncologyoralpackagedpackagingpharmaceuticpharmaceuticalpharmacologicalpharmacologyprescriptionreceptorrenalrenaltivozanibtreatmenttubtyrosineunhealthyvegfwhite
Loading